div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documente-2016-10-11-efr9-l-01-4aq-z-3-cyp2c19-4-a-0-01-a-2-iqhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: 약학정보원 · 2016 10 11 · Efr9-l 01 4aQ-Z 3 : CYP2C19 4 a 0 01 A 2 *ÅIQ l 01 10 intolerance Lapp Lapp lactase deficiency malabsorption -SQ-I o OF 27% -qæ loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader036fdocumentsinreader036viewer202208141160ac9d25cc653a4dcf7b5094html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documente-2016-10-11-efr9-l-01-4aq-z-3-cyp2c19-4-a-0-01-a-2-iqhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: 약학정보원 · 2016 10 11 · Efr9-l 01 4aQ-Z 3 : CYP2C19 4 a 0 01 A 2 *ÅIQ l 01 10 intolerance Lapp Lapp lactase deficiency malabsorption -SQ-I o OF 27% -qæ loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader036fdocumentsinreader036viewer202208141160ac9d25cc653a4dcf7b5094html5thumbnails2jpg width=140 height=200 divdiv